| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 09/11/2003 | US20030171359 Suitable for treatment of illnesses characterised by excessive or abnormal cell proliferation; viral, bacterial, fungal and/or parasitic infections, skin diseases, bone diseases, cardiovascular diseases |
| 09/11/2003 | US20030171357 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/11/2003 | US20030171347 Sigma receptor antagonist compounds that have anti-cocaine properties. These sigma receptor antagonists are useful in the treatment of cocaine overdose and addiction as well as movement disorders. The sigma receptor antagonists of the |
| 09/11/2003 | US20030170178 For therapy and diagnosis of infectious diseases; diseases characterised by cellular hyperproliferation such as tumours, psoriasis, actinic keratosis, atheromas, endoarterial hyperplasia, prostate hyperplasia; for sterilization of blood |
| 09/10/2003 | EP1342722A1 Phthalocyanine compounds used in inks for ink jet printing |
| 09/10/2003 | EP1341794A1 Fungicidal 6-(trifluoromethyl-phenyl)-triazolopyrimidines |
| 09/10/2003 | EP1341771A2 Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors |
| 09/10/2003 | EP1341540A2 Tyrosine kinase inhibitors |
| 09/10/2003 | EP1341531A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 09/10/2003 | EP1259513B1 A NOVEL CRYSTALLINE FORM OF N- 4- 2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO 2,3-d]PYRIMIDIN-5-YL)ETHYL]BENZOYL]-L-GLUTAMIC ACID AND PROCESS THEREFOR |
| 09/10/2003 | EP1127871B1 New esters derived from substituted phenyl-cyclohexyl compounds |
| 09/10/2003 | CN1441805A Antitumoral analogue of Et-743 |
| 09/10/2003 | CN1441804A Tetrahydro-heterocyclozaepinyl pyrimidine derivatives |
| 09/10/2003 | CN1441803A Indoloquinazolinones |
| 09/10/2003 | CN1441802A Process for preparing pyrazolopyrimidinone derivatives for treatment of impotence |
| 09/10/2003 | CN1441779A Proline derivatives and use thereof as drugs |
| 09/10/2003 | CN1440971A Vitronectin receptor antagnist, its preparation and use |
| 09/09/2003 | US6617437 Modified oligonucleotide of given formula; useful in diagnostics and therapeutics |
| 09/09/2003 | US6617339 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 09/09/2003 | US6617326 Imidazo-triazine derivatives as ligands for GABA receptors |
| 09/09/2003 | US6617324 Substituted pyrazoles as p38 kinase inhibitors |
| 09/09/2003 | CA2263566C Substituted 6,5-hetero-bicyclic derivatives |
| 09/09/2003 | CA2138026C Novel 1,4-dihydroquinoxaline-2,3-diones and uses therefor as glycine receptor antagonists |
| 09/04/2003 | WO2003073076A1 Reagent for determining the absolute configuration of chiral compound and determination method |
| 09/04/2003 | WO2003072581A1 Cyclo[n]pyrroles and methods thereto |
| 09/04/2003 | WO2003072580A1 1-[ALKYL], 1-[HETEROARYL)ALKYL] AND 1-[ARYL)ALKYL]-7-(PYRIMIDIN-4-YL)-IMADAZO[1,2-a]PYRIMIDIN-5(1H)-ONE DERIVATIVES |
| 09/04/2003 | WO2003072579A1 HETEROARYL SUBSTITUTED 2-PYRIDINYL AND 2-PYRIMIDINYL -6,7,8,9- TETRAHYDROPYRIMIDO[1,2-a] PYRIMIDIN-4-ONE DERIVATIVES |
| 09/04/2003 | WO2003072578A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
| 09/04/2003 | WO2003072551A1 Uracil-thioether |
| 09/04/2003 | WO2003072550A1 Novel fused ring indazole compounds |
| 09/04/2003 | WO2003072082A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 09/04/2003 | WO2003048120A3 2-aryl pyrrologpyrimidines for a1 and a3 receptors |
| 09/04/2003 | WO2003047505A3 Topoisomerase poison agents |
| 09/04/2003 | WO2003045313A3 2-aminoquinoline compounds |
| 09/04/2003 | WO2003024967A3 Indolizines as kinase protein inhibitors |
| 09/04/2003 | US20030166926 Pyrroloazepine derivatives |
| 09/04/2003 | US20030166921 Multielectron redox catalysts |
| 09/04/2003 | US20030166701 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 09/04/2003 | US20030166690 Use of compounds for decreasing activity of hormone-sensitive |
| 09/04/2003 | US20030166687 Alpha-hydroxy,-amino and -fluoro derivatives of beta-sulphonyl hydroxamic acids as matrix metalloproteinases inhibitors |
| 09/04/2003 | US20030166668 Substituted heteroarylalkanoic acids |
| 09/04/2003 | US20030166657 Treating an optically pure enantimer of zopiclone with 1-chloroethyl chloroformate or an azodicarboxylate followed hydrolysis; modulation of benzodiazepine receptors; sleep and behavioral disorders; anxiolytic agents |
| 09/04/2003 | US20030166649 E.g., 4-(2-(1-Benzhydryl-2-(2-((benzylsulfonyl)amino)ethyl)-5-chloro-1H-indol-3 -yl)ethoxy)benzoic acid; inhibitors of phospholipase enzymes, esp. phospholipase A2; antiarthritic and -inflammatory agents; analgesics; rheumatoid diseases |
| 09/04/2003 | US20030166644 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 09/04/2003 | US20030166640 Heterocyclic amides and/or isosteres used as antiinflammatory agents or for prophylaxis of nervous system disorders; combinatorial chemistry; substance P antagonists |
| 09/04/2003 | US20030165873 For isolating ligand binding polypeptides; fusion proteins; drug screening; kits; surface plasmon resonance |
| 09/04/2003 | US20030165716 Dendrimers according to present invention which can be used for incorporation into light emitting devices have core and/or branches comprising electroluminescent or charge-transporting chromophores (conjugated units) |
| 09/04/2003 | US20030165640 Filters for electronic display device |
| 09/04/2003 | US20030165426 Use of novel metalloporphyrins as imageable tumor-targeting agents for radiation therapy |
| 09/04/2003 | CA2662899A1 Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same |
| 09/04/2003 | CA2477287A1 Uracil-thioether |
| 09/04/2003 | CA2475773A1 Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity |
| 09/03/2003 | EP1340761A1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives |
| 09/03/2003 | EP1340760A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives |
| 09/03/2003 | EP1340759A1 1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-(pyrimidin-4-yl)-imidazo[1,2-a]pyrimidin-5(1H)-one derivatives |
| 09/03/2003 | EP1340758A1 Heteroaryl substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)one derivatives |
| 09/03/2003 | EP1339719A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 09/03/2003 | EP1339718A1 Hydantoin compounds useful as anti-inflammatory agents |
| 09/03/2003 | EP1339708A2 Indole-type inhibitors of p38 kinase |
| 09/03/2003 | EP1339701A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 09/03/2003 | EP1339696A1 Benzyl(idene)-lactams and their use as 5ht1-receptor ligands |
| 09/03/2003 | EP1339684A1 Mch antagonists and their use in the treatment of obesity |
| 09/03/2003 | EP1339410A1 Use of pyrazolo 4,3-d]pyrimidines |
| 09/03/2003 | EP1339402A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 09/03/2003 | EP1250339B1 Porphyrins and related compounds |
| 09/03/2003 | EP1095038B1 Antagonists of gonadotropin releasing hormone |
| 09/03/2003 | EP0966323B1 Catalysts and methods for catalytic oxidation |
| 09/03/2003 | CN1440414A Synthesis of cuttlefish compound |
| 09/03/2003 | CN1440411A Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 09/03/2003 | CN1440410A Diazabicyclic central nervous systems active agents |
| 09/03/2003 | CN1440409A Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes |
| 09/03/2003 | CN1440408A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/03/2003 | CN1440406A 黑皮质素受体配体 Melanocortin receptor ligands |
| 09/03/2003 | CN1440398A Substituted phthalides as anti-convulsive drugs |
| 09/03/2003 | CN1440393A Cyclic compounds |
| 09/03/2003 | CN1440391A Propane-1,3-dione derivatives |
| 09/03/2003 | CN1440287A Method of treating peripheral vascular diseases, peripheral neuropathies, and automatic neuropathies |
| 09/03/2003 | CN1439642A Nonmetallic phthalocyanine and preparation and application thereof |
| 09/03/2003 | CN1439638A Preparation of tetrahydrobenzothiogenin oxidate containing antimer richfully |
| 09/03/2003 | CN1439631A Substituted sulfamide (thio) carbonyl compounds |
| 09/03/2003 | CN1120166C New class of benzoporphyrin derivative photoactive compounds |
| 09/02/2003 | US6613944 Process to produce 3-carbon amino alcohol salts |
| 09/02/2003 | US6613776 Protein serine/threonine kinase inhibitors used for treating diseases such as cancer, diabetes and Alzheimer's disease |
| 09/02/2003 | US6613771 Prevent human retroviral reproduction, infections |
| 09/02/2003 | US6613769 Tryptase inhibitors |
| 09/02/2003 | US6613760 Indole derivatives and their use as MCP-1 receptor antagonists |
| 09/02/2003 | US6613456 Organic electroluminescent device |
| 08/28/2003 | WO2003070731A2 Azabicyclic compounds for the treatment of disease |
| 08/28/2003 | WO2003070730A1 Pyrrolopyrimidine derivative |
| 08/28/2003 | WO2003070729A1 Pyrrolopyrimidine derivatives |
| 08/28/2003 | WO2003070728A2 Azabicyclo-substituted benzoylamides and thioamides for treatment of cns-related disorders |
| 08/28/2003 | WO2003070709A1 Novel phenylalanine derivative |
| 08/28/2003 | WO2003070707A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 08/28/2003 | WO2003070706A1 Tricyclic pyrazole derivatives for the treatment of inflammation |
| 08/28/2003 | WO2003070236A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/28/2003 | WO2003070230A1 Use of agents that modulate pde11a activity |
| 08/28/2003 | WO2003031447A3 Pyrimidine derivatives |
| 08/28/2003 | WO2003027116A3 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |
| 08/28/2003 | WO2003027066A3 Methods of making porphyrins and related compounds with lewis acid |
| 08/28/2003 | WO2002074293A3 Methods for restoring cognitive function following systemic stress |